Featured Stories

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

J.J. Fuds, Inc. Pet Food Recalled - Listeria Contamination

J.J. Fuds, Inc. Pet Food Recalled Over Potential Listeria Contamination

J.J. Fuds, has recalled a specific lot of its J.J. Fuds Chicken Tender Chunks Pet Food over potential contamination with the dangerous, Listeria monocytogenes pathogen.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Flu Vaccine Recalled Over Potency Problem

Drug maker GlaxoSmithKline (GSK) has announced a voluntary recall for the remaining doses of its 2014-2015 Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes (PFS) flu vaccine. The company discovered a reduction in the vaccine’s potency that may reduce the vaccine’s effectiveness.

Glaxo notified the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) about the recall and the recall has been posted by the two agencies and by the company. Thirteen lots of the vaccine are affected by the recall: 2B472, 379MY, 42N4L, 5AZ7H, 9A3ZM, ZS95Z, A2PK7, AR57J, DR4GF, YF5DT, F45C5, T3J4S, and XP4J2. GSK has sent a letter to customers who purchased Flulaval Quadrivalent PFS with directions for returning any unused vaccine from these lots. Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals |

Accident Involving School Bus and Truck in Queens Leaves Four People Injured

A school bus filled with 22 children hit a truck in Queens, leaving four people seriously injured. According to New York Daily News, the Penske box truck was headed southbound on Clearview Expressway when it was struck by the school bus on Hillside Ave. near Hollis Court Blvd. In Jamaica Estates. After being hit the by school bus, the truck jumped the curb and slammed into a sidewalk fruit market.

The truck hit a 34-year-old woman and three other pedestrians before hitting the product stand. Witnesses said the awning collapsed, causing fruits and vegetables to fly everywhere. The injured pedestrians were taken to Jamaica Hospital and Long Island Jewish Medical Center. Officials said the injuries were serious, but non-life threatening. The first woman hit suffered a critical injury, but was stabilized by doctors at Jamaica Hospital. Continue reading

Posted in Legal News |

Toro Recycler Mowers Recalled Due to Incorrect Blade Assembly

According to an April 16, 2015 recall alert posted on the U.S. Consumer Products Safety Commission (CPSC) website, Toro has recalled its walk behind power mower because the wrong blade driver was installed during assembly. This error can result in the blade breaking and lead to an injury, the alert states. Customers affected by the recall should stop using the mowers and contact Toro for a free repair. Continue reading

Posted in Legal News |

Jury in Washington State Awards $1 Million to Plaintiff “Perceived” as Whistleblower

Continue reading

Posted in Legal News, Whistleblower |

OriGen VV13F Reinforced Dual Lumen ECMO Catheters Recalled Due to Risk of Tube Separation

OriGen Biomedical recalled one lot of 51 VV13F Reinforced Dual Lumen ECMO Catheters, according to a recall alert posted on the U.S. Food and Drug Administration’s (FDA’s) website. The devices were recalled due to the risk of the clear extension tube separating from the hub in which it is inserted. Intervention may be needed to prevent permanent impairment or damage if this occurs. The recall affects lot N18549, which expires 09/2018. OriGen knows of at least one product failure, which is associated with a serious adverse event that led to a serious patient injury, the recall indicated. Continue reading

Posted in Legal News |

Beech-Nut Recalls Baby Food Over Possible Glass Contamination

On Tuesday, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced that Beech-Nut Nutrition is recalling approximately 1,920 pounds of baby food products that may be contaminated with small pieces of glass.

The recalled baby food was produced on December 12, 2014. The following product is subject to recall:

  • 4-oz. glass jars containing “Stage 2 Beech-Nut CLASSICS sweet potato & chicken”

Continue reading

Posted in Defective Products, Food Products | Tagged , , , , |

9/11 Responders and Workers Release Video Urging Extension of Zadroga Act

9/11 Responders & Workers Release Zadroga Act Video

9/11 Responders & Workers Release Zadroga Act Video

An advocacy group for 9/11 responders and clean-up workers, Citizens for the Extension of the James Zadroga Act, has released a video, urging Congress to renew the James Zadroga 9/11 Health and Compensation Act. The Zadroga Act provides treatment and compensation for those who were injured or became ill after exposure to toxins in the aftermath of the 9/11 World Trade Center terrorist attacks.

The World Trade Center Health Program and the September 11th Victim Compensation Fund— key provisions of the act—will expire in October 2015 and October 2016, respectively, unless the Zadroga Act is renewed. U.S. Senator Kirsten Gillibrand is leading the effort for the Zadroga Act renewal. Gillibrand was a sponsor of the original legislation in 2010. Continue reading

Posted in Health Concerns, Toxic Substances, Zadroga Act Claims | Tagged , , , , |

Concern About Conflicts of Interest in FDA Dietary Supplement Regulators

Concern About Conflicts of Interest in FDA Regulators

Concern About Conflicts of Interest in FDA Regulators

The Food and Drug Administration (FDA) is facing criticism of its regulation of dietary supplements containing a dangerous stimulant. The stimulant is BMPEA, a chemical nearly identical to amphetamine. BPMEA is added to weight-loss and workout products to enhance their effect.

BPMEA has never been tested for safety and effectiveness in humans and is not a permissible ingredient in dietary supplements. The FDA was the first agency to suspect that BMPEA had been added to supplements that listed the little-known plant acacia rigidula among the ingredients. Experts say that plant listings like this are often an indication that the manufacturer is trying to disguise a chemical additive as a natural botanical extract, the New York Times reports. Continue reading

Posted in Defective Products, Health Concerns | Tagged , , , |

Tri-Methyl Xtreme Supplements May Lead to Liver Damage, FDA Says

Tri-Methyl Xtreme Supplements May Lead to Liver Damage

Tri-Methyl Xtreme Supplements May Lead to Liver Damage

The U.S. Food and Drug Administration (FDA) is warning that Tri-Methyl Xtreme, a muscle-building supplement sold by Las Vegas company Extreme Products Group, has been linked to liver damage. According to Associated Press, the supplement was linked to three reported injuries in California, New Jersey and Utah. The FDA began investigating the product following these reports.

Tri-Methyl Xtreme claims to contain anabolic steroids, although it is sold as a dietary supplement. Dr. Charles Lee of the FDA drug center’s office of compliance said that anabolic steroids “may have a range of serious adverse effects on many organ systems, and the damage may be irreversible,” according to Wall Street Journal. The FDA warned that these chemicals can also negatively impact cholesterol levels, increase the risk of heart attack and stroke, cause masculinity in women and lead to testicle shrinkage. Continue reading

Posted in Legal News | Tagged , , , , |

FDA Warns Wrinkle Cream Maker About Overstated Claims

FDA Warns Wrinkle Cream Maker About Overstated Claims

FDA Warns Wrinkle Cream Maker About Claims

The Food and Drug Administration (FDA) is warning the beauty industry about some of the claims being made for some of its products. Five warnings letters have gone out to companies since November.

The most recent warning letter went out to StriVectin, whose wrinkle creams are sold by a wide range retailers, including Costco and Nordstrom, the Today show reports. The FDA objects to language in the ads that makes the products seem like drugs, not cosmetics. The language includes Continue reading

Posted in Defective Products | Tagged , , , , |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.